Affimer reagents enable targeted delivery of therapeutic agents and RNA via virus-like particlesSophie E. Roberts(University of Leeds), Darren C. Tomlinson(St James's University Hospital)iScienceJuly 5, 202410.1016/j.isci.2024.110461Cited by 3SaveCiteExport RISWatch citationsRelated PapersFGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLCγ/COX-2-Mediated Mechanisms|PLoS ONE|2012|92RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric site|Nature Communications|2021|43Targeting Grb2 SH3 Domains with Affimer Proteins Provides Novel Insights into Ras Signalling Modulation|Biomolecules|2024|3